| Donna Marsh, LPC | |
|
110 Medical Center Dr, Clanton, AL 35045-2332 | |
| (205) 755-5933 | |
| (205) 755-8882 |
| Full Name | Donna Marsh |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 110 Medical Center Dr, Clanton, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356409924 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 1977 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Donna Marsh, LPC Po Box 689, Calera, AL 35040-0689 Ph: (205) 755-8800 | Donna Marsh, LPC 110 Medical Center Dr, Clanton, AL 35045-2332 Ph: (205) 755-5933 |
News Archive
Over the past two decades, the number of adults consuming sugar-sweetened beverages such as soft drinks, fruit drinks and punches has increased dramatically, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
A team led by structural biologists at The Scripps Research Institute has taken a big step toward understanding the intricate molecular mechanism of a metabolic enzyme produced in most forms of life on Earth.
Clinical results from a Phase IIb study showed that MK-4305, Merck's investigational dual orexin receptor antagonist, was significantly more effective than placebo (p<0.005) in improving overall sleep efficiency at night one and at the end of week four in patients with primary insomnia. MK-4305 was generally well-tolerated in the study. Orexins are neuropeptides (chemical messengers) that are released by specialized neurons in the hypothalamus region of the brain and are believed to be an important regulator of the brain's sleep-wake process.
The Wistar Institute today obtained a U.S. patent for a novel synthetic vaccine technology with the potential for further development into a universal flu vaccine which could eliminate the need for annual flu shots and protect against future flu pandemics.
Silence Therapeutics plc, a leading global biotechnology company dedicated to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases, today provides a year-end update on trading and the offer-period.
› Verified 3 days ago
Bethany Chappell, Counselor Medicare: Not Enrolled in Medicare Practice Location: 808 Lay Dam Rd, Clanton, AL 35045 Phone: 205-280-7733 | |
Wanda Gothard, Counselor Medicare: Not Enrolled in Medicare Practice Location: 808 Lay Dam Rd, Clanton, AL 35045 Phone: 205-280-7733 | |
Wanda Bowden, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 507 Lay Dam Rd, Clanton, AL 35045 Phone: 205-624-5854 Fax: 205-000-0000 | |
Neely Elizabeth Haynes, ALC Counselor Medicare: Not Enrolled in Medicare Practice Location: 808 Lay Dam Rd, Clanton, AL 35045 Phone: -- | |
Katherine Killette Anderson, ALC Counselor Medicare: Not Enrolled in Medicare Practice Location: 808 Lay Dam Rd, Clanton, AL 35045 Phone: 205-280-7733 | |
Mesha Cain, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 808 Lay Dam Road, Clanton, AL 35045 Phone: 205-280-7733 Fax: 205-280-7737 | |
Melissa Giles Bolin, ALC Counselor Medicare: Not Enrolled in Medicare Practice Location: 272 Wellness Center Dr, Clanton, AL 35045 Phone: 205-280-7733 |